The antagonism between IFN-α and IL-1β signaling is well described (Guarda et al., 2011) and further substantiated in vivo by the induction of an IFN signature in the blood of sJIA patients after anakinra treatment (Quartier et al., 2011). This evidence concerns the gene IFNA2 and systemic-onset juvenile idiopathic arthritis.